Abstracts - faqs.org

Abstracts

Business, general

Search abstracts:
Abstracts » Business, general

Netscape plays it cool as rival is sued

Article Abstract:

Netscape Communications Corp. is being perceived as dependent on the Justice Department's antitrust suit against Microsoft to maintain its market position, or even to survive. The suit focusing on Microsoft's browser comes too late to help - to maintain market share, Netscape began to give away its browser for free in January 1998, killing a business that was worth $180 million in 1996. Netscape current operates two businesses: selling Web management software (worth about $400 million annually) and selling ads and services on its Web site (worth about $100 million annually).

Comment:

Perceived as dependent on Justice Dept's antitrust suit against Microsoft to maintain its market position

Author: Pollack, Andrew
Publisher: The New York Times Company
Publication Name: The New York Times
Subject: Business, general
ISSN: 0362-4331
Year: 1998
Software Publishers, Communication Software Pkgs, Legal/Government Regulation, Microsoft Corp., Telecommunications software, Netscape Communications Corp.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Lilly pays big fee up front to share in rival of Viagra

Article Abstract:

Icos Corp., a biotechnology company which owns the rights to a new anti-impotency drug, will form a joint venture with Eli Lilly and Company. Industry analysts have said that Eli Lilly has agreed to pay a $75 million up-front fee to Bothell-Wash.-based Icos as part of an agreement for the joint development, marketing and sale of the drug, known as IC351. Analysts also report that the drug may be superior to Viagra, Pfizer's best-selling anti-impotency drug, because it is more selective in blocking the enzyme that prevents erections.

Comment:

Will form joint venture with ICOS Corp. for joint development, marketing and sale of new anti-impotency drug

Author: Pollack, Andrew
Publisher: The New York Times Company
Publication Name: The New York Times
Subject: Business, general
ISSN: 0362-4331
Year: 1998
Joint ventures, Pharmaceutical Preparation Manufacturing, New Products/Services, Licensing/Sales Agreements, Genito-Urinary Preps NEC, Eli Lilly and Co., Genitourinary agents, ICOS Corp.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Investors cool to Hilton plan; stock tumbles

Article Abstract:

Hilton Hotels Corporation announced that it was splitting itself into individual lodging and gaming companies. The company also said that it was merging with Grand Casinos Inc. The moves were an attempt by Hilton to increase stockholder value. Grand Casino is Mississippi's largest casino operator. Investors were disappointed however, that Hilton did not merge its new hotel firm with Ladbroke Group PLC.

Comment:

Announced that it was splitting itself into individual lodging and gaming companies and merging with Grand Casinos

Author: Pollack, Andrew
Publisher: The New York Times Company
Publication Name: The New York Times
Subject: Business, general
ISSN: 0362-4331
Year: 1998
Hotels & Motels, Hotels (except Casino Hotels) and Motels, Hotels and motels, Hilton Hotels Corporation

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United States, Article
Similar abstracts:
  • Abstracts: Investment co. (domestic) industry. Investment company (domestic) industry
  • Abstracts: For Microsoft, humbled may not mean defeated; Legal issues count more than many miscues
  • Abstracts: Protests held against Windows system. Gates hits $100 billion mark, more or less. 'Microsofties' say they're right as rain
  • Abstracts: Pet project: Biotechs switch from drugs for man to drugs for man's best friends. FDA allows large-scale trial of AIDS vaccine
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.